Novo's Suit Over Compounded Weight-Loss Drug Is Tossed

By Beth JoJack · November 9, 2023, 9:09 PM EST

A Florida federal judge has issued an order dismissing Novo Nordisk Inc.'s suit against a Florida independent pharmacy for selling compounded semaglutide, a peptide also found in Ozempic, Novo's blockbuster diabetes...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novo Nordisk Inc. v. Brooksville Pharmaceuticals Inc.

Case Number

8:23-cv-01503

Court

Florida Middle

Nature of Suit

Personal Property: Other

Date Filed

July 06, 2023